Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

Table of Contents

August 1, 2024; Volume 65,Issue 8

This Month in JNM

  • You have access
    This Month in JNM
    Journal of Nuclear Medicine August 1, 2024, 65 (8) 6A;

Discussions with Leaders

  • You have access
    Illuminating Cardiac Function
    Heinrich Schelbert, Heiko Schöder and Johannes Czernin
    Journal of Nuclear Medicine August 1, 2024, 65 (8) 1163-1165; DOI: https://doi.org/10.2967/jnumed.124.268302

The State of the Art

  • An International Study of Factors Affecting Variability of Dosimetry Calculations, Part 3: Contribution from Calculating Absorbed Dose from Time-Integrated Activity
    Open Access
    An International Study of Factors Affecting Variability of Dosimetry Calculations, Part 3: Contribution from Calculating Absorbed Dose from Time-Integrated Activity
    Julia Brosch-Lenz, Sara Kurkowska, Eric Frey, Yuni K. Dewaraja, John Sunderland and Carlos Uribe
    Journal of Nuclear Medicine August 1, 2024, 65 (8) 1166-1172; DOI: https://doi.org/10.2967/jnumed.123.267293

Issues and Controversies

  • You have access
    Facilitating the End of the Linear No-Threshold Model Era
    Mohan Doss
    Journal of Nuclear Medicine August 1, 2024, 65 (8) 1173-1174; DOI: https://doi.org/10.2967/jnumed.124.267868

Oncology

  • Clinical

    • BRIEF COMMUNICATION

      • Dose–Response Relationship in Patients with Liver Metastases from Neuroendocrine Neoplasms Undergoing Radioembolization with <sup>90</sup>Y Glass Microspheres
        You have access
        Dose–Response Relationship in Patients with Liver Metastases from Neuroendocrine Neoplasms Undergoing Radioembolization with 90Y Glass Microspheres
        Masao Watanabe, Stephan Leyser, Jens Theysohn, Benedikt Schaarschmidt, Johannes Ludwig, Wolfgang P. Fendler, Alexandros Moraitis, Harald Lahner, Annie Mathew, Ken Herrmann and Manuel Weber
        Journal of Nuclear Medicine August 1, 2024, 65 (8) 1175-1180; DOI: https://doi.org/10.2967/jnumed.124.267774
    • Diagnostic Performance of <sup>18</sup>F-FDG PET/CT According to Delay After Treatment to Detect Subclinical Recurrence of Head and Neck Squamous Cell Carcinoma
      You have access
      Diagnostic Performance of 18F-FDG PET/CT According to Delay After Treatment to Detect Subclinical Recurrence of Head and Neck Squamous Cell Carcinoma
      Camille Clement, Jean-Christophe Leclère, Clémentine Maheo, Romain Le Pennec, Gregoire Le Gal, Olivier Delcroix, Philippe Robin, Jean Rousset, Valentin Tissot, Aziliz Gueguen, Maryne Allio, Vincent Bourbonne, Ulrike Schick, Remi Marianowski, Pierre-Yves Salaun and Ronan Abgral
      Journal of Nuclear Medicine August 1, 2024, 65 (8) 1181-1187; DOI: https://doi.org/10.2967/jnumed.124.267391
    • Fibroblast Activation Protein–Directed Imaging Outperforms <sup>18</sup>F-FDG PET/CT in Malignant Mesothelioma: A Prospective, Single-Center, Observational Trial
      You have access
      Fibroblast Activation Protein–Directed Imaging Outperforms 18F-FDG PET/CT in Malignant Mesothelioma: A Prospective, Single-Center, Observational Trial
      Lukas Kessler, Felix Schwaning, Martin Metzenmacher, Kim Pabst, Jens Siveke, Marija Trajkovic-Arsic, Benedikt Schaarschmidt, Marcel Wiesweg, Clemens Aigner, Till Plönes, Kaid Darwiche, Servet Bölükbas, Martin Stuschke, Lale Umutlu, Michael Nader, Dirk Theegarten, Rainer Hamacher, Wilfried E.E. Eberhardt, Martin Schuler, Ken Herrmann, Wolfgang P. Fendler and Hubertus Hautzel
      Journal of Nuclear Medicine August 1, 2024, 65 (8) 1188-1193; DOI: https://doi.org/10.2967/jnumed.124.267473
    • Prognostic Value of <sup>18</sup>F-FDG PET/CT Assessment After Radiotherapy of Squamous Cell Carcinoma of the Anus in Patients from the National Multicentric Cohort FFCD-ANABASE
      You have access
      Prognostic Value of 18F-FDG PET/CT Assessment After Radiotherapy of Squamous Cell Carcinoma of the Anus in Patients from the National Multicentric Cohort FFCD-ANABASE
      Virginie Combet-Curt, Chloé Buchalet, Karine Le Malicot, Claire Lemanski, Emmanuel Deshayes, Nathalie Bonichon-Lamichhane, Astrid Lièvre, Florence Huguet, Ghoufrane Tlili and Véronique Vendrely
      Journal of Nuclear Medicine August 1, 2024, 65 (8) 1194-1201; DOI: https://doi.org/10.2967/jnumed.124.267626
    • Diverse Imaging Methods May Influence Long-Term Oncologic Outcomes in Oligorecurrent Prostate Cancer Patients Treated with Metastasis-Directed Therapy (the PRECISE-MDT Study)
      Open Access
      Diverse Imaging Methods May Influence Long-Term Oncologic Outcomes in Oligorecurrent Prostate Cancer Patients Treated with Metastasis-Directed Therapy (the PRECISE-MDT Study)
      Matteo Bauckneht, Francesco Lanfranchi, Domenico Albano, Luca Triggiani, Flavia Linguanti, Luca Urso, Rosario Mazzola, Alessio Rizzo, Elisa D’Angelo, Francesco Dondi, Eneida Mataj, Gloria Pedersoli, Elisabetta Maria Abenavoli, Luca Vaggelli, Beatrice Detti, Naima Ortolan, Antonio Malorgio, Alessia Guarneri, Federico Garrou, Matilde Fiorini, Serena Grimaldi, Pietro Ghedini, Giuseppe Carlo Iorio, Antonella Iudicello, Guido Rovera, Giuseppe Fornarini, Diego Bongiovanni, Michela Marcenaro, Filippo Maria Pazienza, Giorgia Timon, Matteo Salgarello, Manuela Racca, Mirco Bartolomei, Stefano Panareo, Umberto Ricardi, Francesco Bertagna, Filippo Alongi, Salvina Barra, Silvia Morbelli, Gianmario Sambuceti and Liliana Belgioia
      Journal of Nuclear Medicine August 1, 2024, 65 (8) 1202-1209; DOI: https://doi.org/10.2967/jnumed.124.267586
    • Prostate-Specific Membrane Antigen–Targeted Imaging and Its Correlation with HOXB13 Expression
      Open Access
      Prostate-Specific Membrane Antigen–Targeted Imaging and Its Correlation with HOXB13 Expression
      Duminduni Hewa Angappulige, Nimrod S. Barashi, Nicholas Pickersgill, Cody Weimholt, Jingqin Luo, Ghazal Shadmani, Ziad Tarcha, Sampanna Rayamajhi, Nupam P. Mahajan, Gerald L. Andriole, Barry A. Siegel, Eric H. Kim and Kiran Mahajan
      Journal of Nuclear Medicine August 1, 2024, 65 (8) 1210-1216; DOI: https://doi.org/10.2967/jnumed.123.267301

Theranostics

  • Clinical

    • The Role of Fibroblast Activation Protein in Glioblastoma and Gliosarcoma: A Comparison of Tissue, <sup>68</sup>Ga-FAPI-46 PET Data, and Survival Data
      You have access
      The Role of Fibroblast Activation Protein in Glioblastoma and Gliosarcoma: A Comparison of Tissue, 68Ga-FAPI-46 PET Data, and Survival Data
      Christoph Oster, Lukas Kessler, Tobias Blau, Kathy Keyvani, Kim M. Pabst, Wolfgang P. Fendler, Pedro Fragoso Costa, Lazaros Lazaridis, Teresa Schmidt, Jonas Feldheim, Daniela Pierscianek, Hans Ulrich Schildhaus, Ulrich Sure, Yahya Ahmadipour, Christoph Kleinschnitz, Nika Guberina, Martin Stuschke, Cornelius Deuschl, Björn Scheffler, Ken Herrmann, Sied Kebir and Martin Glas
      Journal of Nuclear Medicine August 1, 2024, 65 (8) 1217-1223; DOI: https://doi.org/10.2967/jnumed.123.267151
    • PET/CT-Based Absorbed Dose Maps in <sup>90</sup>Y Selective Internal Radiation Therapy Correlate with Spatial Changes in Liver Function Derived from Dynamic MRI
      You have access
      PET/CT-Based Absorbed Dose Maps in 90Y Selective Internal Radiation Therapy Correlate with Spatial Changes in Liver Function Derived from Dynamic MRI
      Zhonglin Lu, Daniel F. Polan, Lise Wei, Madhava P. Aryal, Kellen Fitzpatrick, Chang Wang, Kyle C. Cuneo, Joseph R. Evans, Molly E. Roseland, Joseph J. Gemmete, Jared A. Christensen, Baljendra S. Kapoor, Justin K. Mikell, Yue Cao, Greta S.P. Mok and Yuni K. Dewaraja
      Journal of Nuclear Medicine August 1, 2024, 65 (8) 1224-1230; DOI: https://doi.org/10.2967/jnumed.124.267421
    • Clinical Trial Protocol for VIOLET: A Single-Center, Phase I/II Trial Evaluation of Radioligand Treatment in Patients with Metastatic Castration-Resistant Prostate Cancer with [<sup>161</sup>Tb]Tb-PSMA-I&amp;T
      You have access
      Clinical Trial Protocol for VIOLET: A Single-Center, Phase I/II Trial Evaluation of Radioligand Treatment in Patients with Metastatic Castration-Resistant Prostate Cancer with [161Tb]Tb-PSMA-I&T
      James P. Buteau, Louise Kostos, Ramin Alipour, Price Jackson, Lachlan McInstosh, Brittany Emmerson, Mohammad B. Haskali, Jing Xie, Elizabeth Medhurst, Rajeev Ravi, Brian D. Gonzalez, Heidi Fettke, Benjamin Blyth, Luc Furic, Katie Owen, Shahneen Sandhu, Declan G. Murphy, Arun A. Azad and Michael S. Hofman
      Journal of Nuclear Medicine August 1, 2024, 65 (8) 1231-1238; DOI: https://doi.org/10.2967/jnumed.124.267650
    • Interreader and Intrareader Reproducibility of <sup>18</sup>F-Flotufolastat Image Interpretation in Patients with Newly Diagnosed or Recurrent Prostate Cancer: Data from Two Phase 3 Prospective Multicenter Studies
      Open Access
      Interreader and Intrareader Reproducibility of 18F-Flotufolastat Image Interpretation in Patients with Newly Diagnosed or Recurrent Prostate Cancer: Data from Two Phase 3 Prospective Multicenter Studies
      Phillip H. Kuo, Giuseppe Esposito, Gary A. Ulaner, Don Yoo, Katherine Zukotynski, Gregory C. Ravizzini, Ross Penny, Matthew P. Miller, Albert Chau, Phillip Davis, Brian F. Chapin, David M. Schuster and on behalf of the SPOTLIGHT and LIGHTHOUSE study groups
      Journal of Nuclear Medicine August 1, 2024, 65 (8) 1239-1243; DOI: https://doi.org/10.2967/jnumed.123.267306
    • Spleen Volume Reduction Is a Reliable and Independent Biomarker for Long-Term Risk of Leukopenia Development in Peptide Receptor Radionuclide Therapy
      You have access
      Spleen Volume Reduction Is a Reliable and Independent Biomarker for Long-Term Risk of Leukopenia Development in Peptide Receptor Radionuclide Therapy
      Lisa Steinhelfer, Friederike Jungmann, Lukas Endrös, Patrick Wenzel, Bernhard Haller, Manuel Nickel, Eva Haneder, Fabian Geisler, Katharina Götze, Alexander von Werder, Matthias Eiber, Markus R. Makowski, Rickmer Braren and Fabian Lohöfer
      Journal of Nuclear Medicine August 1, 2024, 65 (8) 1244-1249; DOI: https://doi.org/10.2967/jnumed.123.267098
  • Basic

    • FEATURED BASIC SCIENCE ARTICLE

      • Synthesis of <sup>64</sup>Cu-, <sup>55</sup>Co-, and <sup>68</sup>Ga-Labeled Radiopharmaceuticals Targeting Neurotensin Receptor-1 for Theranostics: Adjusting In Vivo Distribution Using Multiamine Macrocycles
        You have access
        Synthesis of 64Cu-, 55Co-, and 68Ga-Labeled Radiopharmaceuticals Targeting Neurotensin Receptor-1 for Theranostics: Adjusting In Vivo Distribution Using Multiamine Macrocycles
        German O. Fonseca Cabrera, Xinrui Ma, Wilson Lin, Tao Zhang, Weiling Zhao, Liqin Pan, Xiaomei Li, Todd E. Barnhart, Eduardo Aluicio-Sarduy, Huaifu Deng, Xuedan Wu, Kadalipura P. Rakesh, Zibo Li, Jonathan W. Engle and Zhanhong Wu
        Journal of Nuclear Medicine August 1, 2024, 65 (8) 1250-1256; DOI: https://doi.org/10.2967/jnumed.124.267469
    • Design of a Fibroblast Activation Protein–Targeted Radiopharmaceutical Therapy with High Tumor–to–Healthy-Tissue Ratios
      You have access
      Design of a Fibroblast Activation Protein–Targeted Radiopharmaceutical Therapy with High Tumor–to–Healthy-Tissue Ratios
      Ramesh Mukkamala, Daniel J. Carlson, Nicholas Kaine Miller, Spencer D. Lindeman, Emily Renee Bowen, Pooja Tudi, Taylor Schleinkofer, Owen C. Booth, Abigail Cox, Madduri Srinivasarao and Philip S. Low
      Journal of Nuclear Medicine August 1, 2024, 65 (8) 1257-1263; DOI: https://doi.org/10.2967/jnumed.124.267756

Radiobiology/Dosimetry

  • Clinical

    • Dosimetry of [<sup>177</sup>Lu]Lu-PSMA–Targeted Radiopharmaceutical Therapies in Patients with Prostate Cancer: A Comparative Systematic Review and Metaanalysis
      You have access
      Dosimetry of [177Lu]Lu-PSMA–Targeted Radiopharmaceutical Therapies in Patients with Prostate Cancer: A Comparative Systematic Review and Metaanalysis
      Zachary Ells, Tristan R. Grogan, Johannes Czernin, Magnus Dahlbom and Jeremie Calais
      Journal of Nuclear Medicine August 1, 2024, 65 (8) 1264-1271; DOI: https://doi.org/10.2967/jnumed.124.267452
    • Impact of the Reference Multiple-Time-Point Dosimetry Protocol on the Validity of Single-Time-Point Dosimetry for [<sup>177</sup>Lu]Lu-PSMA-I&amp;T Therapy
      Open Access
      Impact of the Reference Multiple-Time-Point Dosimetry Protocol on the Validity of Single-Time-Point Dosimetry for [177Lu]Lu-PSMA-I&T Therapy
      Sandra Resch, Sibylle I. Ziegler, Gabriel Sheikh, Lena M. Unterrainer, Mathias J. Zacherl, Peter Bartenstein, Guido Böning, Julia Brosch-Lenz and Astrid Delker
      Journal of Nuclear Medicine August 1, 2024, 65 (8) 1272-1278; DOI: https://doi.org/10.2967/jnumed.123.266871

Cardiovascular

  • Clinical

    • Factors Associated with Myocardial Uptake on Oncologic Somatostatin PET Investigations and Differentiation from Myocardial Uptake of Acute Myocarditis
      You have access
      Factors Associated with Myocardial Uptake on Oncologic Somatostatin PET Investigations and Differentiation from Myocardial Uptake of Acute Myocarditis
      Thomas Larive, Caroline Boursier, Marine Claudin, Jeanne Varlot, Laura Filippetti, Olivier Huttin, Véronique Roch, Laetitia Imbert, Matthieu Doyen, Aurélien Lambert, Damien Mandry, Zohra Lamiral, Elodie Chevalier and Pierre-Yves Marie
      Journal of Nuclear Medicine August 1, 2024, 65 (8) 1279-1285; DOI: https://doi.org/10.2967/jnumed.123.267219

Neurology

  • Clinical

    • Performing [<sup>18</sup>F]MFBG Long–Axial-Field-of-View PET/CT Without Sedation or General Anesthesia for Imaging of Children with Neuroblastoma
      Open Access
      Performing [18F]MFBG Long–Axial-Field-of-View PET/CT Without Sedation or General Anesthesia for Imaging of Children with Neuroblastoma
      Lise Borgwardt, Jesper Brok, Kim Francis Andersen, Jacob Madsen, Nicholas Gillings, Marie Øbro Fosbøl, Charlotte Lund Denholt, Ida Nymann Petersen, Louise Sørup Sørensen, Lotte Hahn Enevoldsen, Peter Sandor Oturai, Helle Hjort Johannesen, Liselotte Højgaard, Christina Schulze, Eunice Saxtoft, Flemming Andersen and Barbara Malene Fischer
      Journal of Nuclear Medicine August 1, 2024, 65 (8) 1286-1292; DOI: https://doi.org/10.2967/jnumed.123.267256
  • Basic

    • Noninvasive Diagnostic Method to Objectively Measure Olfaction and Diagnose Smell Disorders by a Molecularly Targeted Fluorescence Imaging Agent
      Open Access
      Noninvasive Diagnostic Method to Objectively Measure Olfaction and Diagnose Smell Disorders by a Molecularly Targeted Fluorescence Imaging Agent
      Dauren Adilbay, Junior Gonzales, Marianna Zazhytska, Paula Demetrio de Souza Franca, Sheryl Roberts, Tara D. Viray, Raik Artschwager, Snehal Patel, Albana Kodra, Jonathan B. Overdevest, Chun Yuen Chow, Glenn F. King, Sanjay K. Jain, Alvaro A. Ordonez, Laurence S. Carroll, Stavros Lomvardas, Thomas Reiner and Nagavarakishore Pillarsetty
      Journal of Nuclear Medicine August 1, 2024, 65 (8) 1293-1300; DOI: https://doi.org/10.2967/jnumed.123.266123

Molecular Imaging

  • Basic

    • <em>h</em>HEPATO-Cy5, a Bimodal Tracer for Image-Guided Hepatobiliary Surgery
      You have access
      hHEPATO-Cy5, a Bimodal Tracer for Image-Guided Hepatobiliary Surgery
      Daphne D.D. Rietbergen, Tessa Buckle, Leon J. Slof, Maarten P. van Meerbeek, Clarize M. de Korne, Mick M. Welling, Matthias N. van Oosterom, Kevin Bauwens, Meta Roestenberg, Julia Kloetzl and Fijs W.B. van Leeuwen
      Journal of Nuclear Medicine August 1, 2024, 65 (8) 1301-1306; DOI: https://doi.org/10.2967/jnumed.123.266715

AI/Advanced Image Analysis

  • Basic

    • RadShap: An Explanation Tool for Highlighting the Contributions of Multiple Regions of Interest to the Prediction of Radiomic Models
      Open Access
      RadShap: An Explanation Tool for Highlighting the Contributions of Multiple Regions of Interest to the Prediction of Radiomic Models
      Nicolas Captier, Fanny Orlhac, Narinée Hovhannisyan-Baghdasarian, Marie Luporsi, Nicolas Girard and Irène Buvat
      Journal of Nuclear Medicine August 1, 2024, 65 (8) 1307-1312; DOI: https://doi.org/10.2967/jnumed.124.267434

Physics and Instrumentation

  • Clinical

    • Validation and Evaluation of a Vendor-Provided Head Motion Correction Algorithm on the uMI Panorama PET/CT System
      Open Access
      Validation and Evaluation of a Vendor-Provided Head Motion Correction Algorithm on the uMI Panorama PET/CT System
      Fei Kang, Zhaojuan Xie, Wenhui Ma, Zhiyong Quan, Guiyu Li, Kun Guo, Xiang Li, Taoqi Ma, Weidong Yang, Yizhang Zhao, Hongyuan Yi, Yumo Zhao, Yihuan Lu and Jing Wang
      Journal of Nuclear Medicine August 1, 2024, 65 (8) 1313-1319; DOI: https://doi.org/10.2967/jnumed.124.267446
    • FEATURED ARTICLE OF THE MONTH

      • Performance Characteristics of the NeuroEXPLORER, a Next-Generation Human Brain PET/CT Imager
        Open Access
        Performance Characteristics of the NeuroEXPLORER, a Next-Generation Human Brain PET/CT Imager
        Hongdi Li, Ramsey D. Badawi, Simon R. Cherry, Kathryn Fontaine, Liuchun He, Shannan Henry, Ansel T. Hillmer, Lingzhi Hu, Nikkita Khattar, Edwin K. Leung, Tiantian Li, Yusheng Li, Chi Liu, Peng Liu, Zhenrui Lu, Stanislaw Majewski, David Matuskey, Evan D. Morris, Tim Mulnix, Negar Omidvari, Suranjana Samanta, Aaron Selfridge, Xishan Sun, Takuya Toyonaga, Tommaso Volpi, Tianyi Zeng, Terry Jones, Jinyi Qi and Richard E. Carson
        Journal of Nuclear Medicine August 1, 2024, 65 (8) 1320-1326; DOI: https://doi.org/10.2967/jnumed.124.267767

The Illustrated Post

  • You have access
    Brain Metabolic Correlates of the Off-Target Effects of Enzalutamide on the Central Nervous System of Patients with Advanced Prostate Cancer
    Matteo Bauckneht, Giuseppe Fornarini, Tania Di Raimondo, Matteo Pardini, Maria Isabella Donegani, Giuseppe Luigi Banna, Massimo Di Maio and Silvia Morbelli
    Journal of Nuclear Medicine August 1, 2024, 65 (8) 1327; DOI: https://doi.org/10.2967/jnumed.124.267526
  • You have access
    [68Ga]Ga-FAPI-46 False-Positive Uptake After Chemotherapy in Nonseminomatous Germ Cell Tumor Metastatic Lesions
    Vinicius Ludwig, Peter George Maliha, John Shen, David Tonnelet, Steve Raman, Mark S. Litwin and Jeremie Calais
    Journal of Nuclear Medicine August 1, 2024, 65 (8) 1328-1329; DOI: https://doi.org/10.2967/jnumed.124.267609

Letters to the Editor

  • You have access
    Nuclear Pharmacy Training in the Era of Theranostics: Toward Meeting the Needs of Nuclear Medicine Patients for Comprehensive Pharmaceutical Care
    Isabelle Laverdière, Gilbert Matte, Martin Darveau and Jean-Mathieu Beauregard
    Journal of Nuclear Medicine August 1, 2024, 65 (8) 1330-1331; DOI: https://doi.org/10.2967/jnumed.124.267603
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine: 65 (8)
Journal of Nuclear Medicine
Vol. 65, Issue 8
August 1, 2024
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)

Issue highlights

  • Performance Characteristics of the NeuroEXPLORER, a Next-Generation Human Brain PET/CT Imager
  • Synthesis of 64Cu-, 55Co-, and 68Ga-Labeled Radiopharmaceuticals Targeting Neurotensin Receptor-1 for Theranostics: Adjusting In Vivo Distribution Using Multiamine Macrocycles
Sign up for alerts

Jump to

  • This Month in JNM
  • Discussions with Leaders
  • The State of the Art
  • Issues and Controversies
  • Oncology
    • Clinical
      • BRIEF COMMUNICATION
  • Theranostics
    • Clinical
    • Basic
      • FEATURED BASIC SCIENCE ARTICLE
  • Radiobiology/Dosimetry
    • Clinical
  • Cardiovascular
    • Clinical
  • Neurology
    • Clinical
    • Basic
  • Molecular Imaging
    • Basic
  • AI/Advanced Image Analysis
    • Basic
  • Physics and Instrumentation
    • Clinical
      • FEATURED ARTICLE OF THE MONTH
  • The Illustrated Post
  • Letters to the Editor
  • Most Cited
  • Most Read
Loading
  • MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry
  • Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine
  • Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
  • Renal and Multiorgan Safety of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
  • High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections
More...
SNMMI

© 2025 SNMMI

Powered by HighWire